UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus

Pharmacoepidemiology and drug safety, 2023-12, Vol.32 (12), p.1395-1405

2023

Volltextzugriff (PDF)

Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan

Pharmacoepidemiology and drug safety, 2024-08, Vol.33 (8), p.e5855-n/a

2024

Volltextzugriff (PDF)

Association between antidepressant use in pregnancy and gestational diabetes mellitus: Results from the Norwegian Mother, Father and Child Cohort Study

Pharmacoepidemiology and drug safety, 2022-02, Vol.31 (2), p.247-256

2022

Volltextzugriff (PDF)

Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe

Pharmacoepidemiology and drug safety, 2021-10, Vol.30 (10), p.1447-1457

2021

Volltextzugriff (PDF)

Utilization of broad‐ versus narrow‐spectrum antibiotics for the treatment of outpatient community‐acquired pneumonia among adults in the United States

Pharmacoepidemiology and drug safety, 2024-04, Vol.33 (4), p.e5779-n/a

2024

Volltextzugriff (PDF)

A basic study design for expedited safety signal evaluation based on electronic healthcare data

Pharmacoepidemiology and drug safety, 2010-08, Vol.19 (8), p.858-868

Schneeweiss, Sebastian

2010

Volltextzugriff (PDF)

Patient characteristics and safety outcomes in new users of ticagrelor and clopidogrel—An observational cohort study in Sweden

Pharmacoepidemiology and drug safety, 2022-02, Vol.31 (2), p.235-246

2022

Volltextzugriff (PDF)

Prenatal exposure to non‐steroidal anti‐inflammatory drugs and risk of attention‐deficit/hyperactivity disorder: A follow‐up study in the Norwegian mother, father and child cohort

Pharmacoepidemiology and drug safety, 2021-10, Vol.30 (10), p.1380-1390

2021

Volltextzugriff (PDF)

Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real‐world example

Pharmacoepidemiology and drug safety, 2020-01, Vol.29 (S1), p.35-44

2020

Volltextzugriff (PDF)

Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study

Pharmacoepidemiology and drug safety, 2015-04, Vol.24 (4), p.368-380

2015

Volltextzugriff (PDF)

Use of dipeptidyl peptidase‐4 inhibitors and the risk of arthralgia: Population‐based cohort and nested case–control studies

Pharmacoepidemiology and drug safety, 2019-04, Vol.28 (4), p.500-506

2019

Volltextzugriff (PDF)

Treatment with rivastigmine or galantamine and risk of urinary incontinence: results from a Dutch database study

Pharmacoepidemiology and drug safety, 2015-03, Vol.24 (3), p.276-285

2015

Volltextzugriff (PDF)

Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome

Pharmacoepidemiology and drug safety, 2015-04, Vol.24 (4), p.353-360

2015

Volltextzugriff (PDF)

Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination

Pharmacoepidemiology and drug safety, 2012-12, Vol.21 (12), p.1350-1358

2012

Volltextzugriff (PDF)

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

Pharmacoepidemiology and drug safety, 2007-10, Vol.16 (10), p.1065-1071

2007

Volltextzugriff (PDF)

Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs

Pharmacoepidemiology and drug safety, 2014-08, Vol.23 (8), p.819-829

2014

Volltextzugriff (PDF)

Time‐related biases in pharmacoepidemiology

Pharmacoepidemiology and drug safety, 2020-09, Vol.29 (9), p.1101-1110

2020

Volltextzugriff (PDF)

Coronary heart disease outcomes in patients receiving antidiabetic agents

Pharmacoepidemiology and drug safety, 2007-07, Vol.16 (7), p.711-725

2007

Volltextzugriff (PDF)

Risk of hyperkalemia associated with selective COX-2 inhibitors

Pharmacoepidemiology and drug safety, 2010-11, Vol.19 (11), p.1194-1198

2010

Volltextzugriff (PDF)

Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study

Pharmacoepidemiology and drug safety, 2016-05, Vol.25 (5), p.569-577

2016

Volltextzugriff (PDF)

Sample size for post-marketing safety studies based on historical controls

Pharmacoepidemiology and drug safety, 2010-08, Vol.19 (8), p.869-875

2010

Volltextzugriff (PDF)

The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada

Pharmacoepidemiology and drug safety, 2009-11, Vol.18 (11), p.1016-1025

2009

Volltextzugriff (PDF)

Randomized, observational, interventional, and real‐world—What's in a name?

Pharmacoepidemiology and drug safety, 2020-11, Vol.29 (11), p.1514-1517

2020

Volltextzugriff (PDF)

The incident user design in comparative effectiveness research

Pharmacoepidemiology and drug safety, 2013-01, Vol.22 (1), p.1-6

2013

Volltextzugriff (PDF)

Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril

Pharmacoepidemiology and drug safety, 2010-03, Vol.19 (3), p.266-272

2010

Volltextzugriff (PDF)

1 – 25 von 587

Suche als RSS-Feed

Aktive Filter

ThemaYoung Adult

KollektionWiley Online Library Full Collection 2018

Zeitschrift / SeriePharmacoepidemiology And Drug Safety

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(587)
Mit Volltextzugriff
(587)

Publikationsform

Artikel
(587)

Sprache

Englisch
(587)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(552)
Pharmacology & Pharmacy
(552)
Public, Environmental & Occupational Health
(552)
Science & Technology
(552)
Humans
(528)
Cohort Studies
(524)
Female
(412)
Male
(369)
Pharmacoepidemiology
(294)
Aged
(290)
Middle Aged
(279)
Adult
(194)
Retrospective Studies
(180)
Risk Factors
(152)
Aged, 80 And Over
(144)
Databases, Factual
(105)
Time Factors
(87)
Follow-Up Studies
(79)
Pharmacology
(79)
Epidemiology
(78)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Online Library
(587)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(587)
MEDLINE
(533)
IngentaConnect Journals
(55)
IngentaConnect Journals
(1)

Zeitschrift / Serie

Pharmacoepidemiol Drug Safety
(1)

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus

Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan

Association between antidepressant use in pregnancy and gestational diabetes mellitus: Results from the Norwegian Mother, Father and Child Cohort Study

Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe

Utilization of broad‐ versus narrow‐spectrum antibiotics for the treatment of outpatient community‐acquired pneumonia among adults in the United States

A basic study design for expedited safety signal evaluation based on electronic healthcare data

Patient characteristics and safety outcomes in new users of ticagrelor and clopidogrel—An observational cohort study in Sweden

Prenatal exposure to non‐steroidal anti‐inflammatory drugs and risk of attention‐deficit/hyperactivity disorder: A follow‐up study in the Norwegian mother, father and child cohort

Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real‐world example

Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study

Use of dipeptidyl peptidase‐4 inhibitors and the risk of arthralgia: Population‐based cohort and nested case–control studies

Treatment with rivastigmine or galantamine and risk of urinary incontinence: results from a Dutch database study

Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome

Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs

Time‐related biases in pharmacoepidemiology

Coronary heart disease outcomes in patients receiving antidiabetic agents

Risk of hyperkalemia associated with selective COX-2 inhibitors

Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study

Sample size for post-marketing safety studies based on historical controls

The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada

Randomized, observational, interventional, and real‐world—What's in a name?

The incident user design in comparative effectiveness research

Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril

Aktive Filter

Suchergebnisse filtern